Видео ютуба по тегу Joan Mannick

Dr. Joan Mannick — mTOR’s Role in Aging
Dr. Joan Mannick — mTOR’s Role in Aging
Joan Mannick on Rapamycin Longevity Series | Turning down mTOR to young levels may be good for aging
Joan Mannick on Rapamycin Longevity Series | Turning down mTOR to young levels may be good for aging
Joan Mannick, MD: The Future of RTB101
Joan Mannick, MD: The Future of RTB101
Targeting Aging Biology to treat aging related diseases by Joan Mannick
Targeting Aging Biology to treat aging related diseases by Joan Mannick
#123–Joan Mannick & Nir Barzilai: Rapamycin and metformin—longevity, immune enhancement, & COVID-19
#123–Joan Mannick & Nir Barzilai: Rapamycin and metformin—longevity, immune enhancement, & COVID-19
Dr. Joan Mannick - Targeting mTOR to Improve Immune Function and Healthspan
Dr. Joan Mannick - Targeting mTOR to Improve Immune Function and Healthspan
Webinar | Joan Mannick, PhD | TORC1 & RTB101 to Improve Immune Health, Decrease COVID-19 Severity
Webinar | Joan Mannick, PhD | TORC1 & RTB101 to Improve Immune Health, Decrease COVID-19 Severity
Targeting the biology of ageing to prevent, treat and reverse age-related diseases | Dr Joan Mannick
Targeting the biology of ageing to prevent, treat and reverse age-related diseases | Dr Joan Mannick
Joan Mannick, MD, on TORC1 Inhibition
Joan Mannick, MD, on TORC1 Inhibition
Joan Mannick at ARDD2023 - Longevity Medicine Day: Longevity medicine therapeutics applied gero...
Joan Mannick at ARDD2023 - Longevity Medicine Day: Longevity medicine therapeutics applied gero...
Joan Mannick - Targeting Disease by Inhibiting mTOR
Joan Mannick - Targeting Disease by Inhibiting mTOR
Warmup Discussion with Jamie Justice, Joan Mannick and George Vradenburg
Warmup Discussion with Jamie Justice, Joan Mannick and George Vradenburg
#Ageing science, #healthspan and the potential to dramatically change how we treat disease
#Ageing science, #healthspan and the potential to dramatically change how we treat disease
Dr. Joan Mannick
Dr. Joan Mannick
Joan Mannick, ResTORbio CMO, at the Longevity Leaders Congress (May 2020)
Joan Mannick, ResTORbio CMO, at the Longevity Leaders Congress (May 2020)
Coronavirus Meets Metabesity: Pandemics and Age-Related Diseases
Coronavirus Meets Metabesity: Pandemics and Age-Related Diseases
Treatment of Aging Related Diseases - TORC1
Treatment of Aging Related Diseases - TORC1
Webinar | COVID-19: Can the Science of Aging Move Us Forward?
Webinar | COVID-19: Can the Science of Aging Move Us Forward?
Metabesity 2020: Immunity Decline and Coronavirus
Metabesity 2020: Immunity Decline and Coronavirus
Roadmap to commercialisation – examining clinical and regulatory pathways for longevity therapeutics
Roadmap to commercialisation – examining clinical and regulatory pathways for longevity therapeutics
UK SPINE Conference 2020: From bench to care home in a time of COVID
UK SPINE Conference 2020: From bench to care home in a time of COVID
Turning Back Time: The Science of Aging
Turning Back Time: The Science of Aging
Metabesity 2020: Registrable Indications
Metabesity 2020: Registrable Indications
Metabesity 2022: Welcome and Introduction to Day 2
Metabesity 2022: Welcome and Introduction to Day 2
Joan MANNICK_Using rapamycin derivatives to treat aging-related diseases in humans
Joan MANNICK_Using rapamycin derivatives to treat aging-related diseases in humans